Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Patient stratification and its predictive value for cardiac events

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Topol, Eric

publication date

  • September 1998

journal

  • European Heart Journal  Journal

abstract

  • In the GUSTO IIb trial, the combined rate of death and non-fatal myocardial infarction for patients with unstable coronary syndromes was nearly 10% despite therapy with aspirin, heparin or hirudin, beta-blockers, nitrates and, in selective patients, calcium channel blockers. Thus, therapy of such patients can be improved. Follow-up and therapy can be optimized if patients can be stratified by risk according to characteristics on admission. In the GUSTO IIb trial, age, low systolic and diastolic blood pressure and high heart rate were important determining factors of outcome in both ST- and non-ST elevation patients. In the TIMI IIIB study, rest pain within the first 48 h in patients with unstable angina or post-myocardial infarction was associated with a higher incidence of cardiac events. In addition, mortality was influenced by the number of leads with ST changes and the extent of ST deflection. Additional data from GUSTO IIa showed that elevated troponin-T levels were associated with a higher incidence of mortality. A similar relationship was shown with troponin-I in the TIMI study. The FRISC trial demonstrated that patients with elevated troponin-T levels treated with a low-molecular-weight heparin had comparable death/myocardial infarction rates to patients without elevated troponin-T levels.

subject areas

  • Acute Disease
  • Anticoagulants
  • Biomarkers
  • Calcium Channel Blockers
  • Clinical Trials as Topic
  • Coronary Disease
  • Electrocardiography
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Platelet Aggregation
  • Platelet Aggregation Inhibitors
  • Prognosis
  • Vasodilator Agents
scroll to property group menus

Research

keywords

  • acute coronary syndromes
  • low-molecular-weight heparin
  • prognostic indices
  • troponin-I
  • troponin-T
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0195-668X

PubMed ID

  • 9790282
scroll to property group menus

Additional Document Info

start page

  • K5

end page

  • K7

volume

  • 19

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support